Blue Current Global Dividend Instl holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
Blue Current Global Dividend Fund Institutional Class BCGDX
- NAV / 1-Day Return 20.58 / −1.39 %
- Total Assets 97.1M
-
Adj. Expense Ratio
1.010%
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Global Large-Stock Value
- Investment Style Large Value
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 1.49%
- Turnover 33%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:37 AM GMT+0
Morningstar’s Analysis BCGDX
Will BCGDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the BCGDX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of BCGDX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Broadcom Inc | 4.07 | 4M | Technology |
Targa Resources Corp | 3.64 | 4M | Energy |
Johnson & Johnson | 3.43 | 3M | Healthcare |
Sandoz Group AG Registered Shares | 3.40 | 3M | Healthcare |
Morgan Stanley | 3.37 | 3M | Financial Services |
Shell PLC ADR (Representing - Ordinary Shares) | 3.27 | 3M | Energy |
Ventas Inc | 3.27 | 3M | Real Estate |
Coca-Cola Co | 3.06 | 3M | Consumer Defensive |
AstraZeneca PLC | 2.98 | 3M | Healthcare |
JPMorgan Chase & Co | 2.82 | 3M | Financial Services |
United States